QuoTrend
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNews
DashboardScreenCompareStrategiesPortfolioSectorsHeatmapsInsiderFuturesForexCryptoCalendarNewsMore
⌘K
Help
QuoTrend
PAGEHome
HomePricingContactHelpTermsPrivacy
Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
© 2026 QuoTrend
Screen

LKFT

QT67Lakefront Biotherapeutics N.V.
NASDAQ·Healthcare·Biotechnology·BE
Latest market price
28.30
-0.07-0.25%
OverviewShort InterestFilings
LKFTQT67Lakefront Biotherapeutics N.V.·NASDAQ
OverviewShort InterestFilings
28.30-0.25%
TA
Loading chart...
Screen all →
VRTX-1.60%$451.63REGN+0.33%$609.94ARGX-1.63%$877.72ALNY-1.64%$278.09RVMD+3.31%$162.99MRNA+3.50%$63.96UTHR-2.70%$536.59BNTX-1.44%$90.89
Snapshot
Index-P/E3.34EPS (ttm)
8.68
Insider Own-
Shs Outstand65.90M
Perf Week-2.21%
Market Cap1.87BForward P/E-EPS next Y-3.25Insider Trans-Shs Float-Perf Month6.35%
Enterprise Value1.80BPEG-EPS next Q-0.94Inst Own-Short Float-Perf Quarter-13.00%
Income560.73MP/S1.56EPS this Y-143.07%Inst Trans-Short Ratio-Perf Half Y-8.94%
Sales1.20BP/B0.50EPS next Y12.96%ROA14.49%Short Interest-Perf YTD-13.46%
Book/sh57.07P/C-EPS next 5Y-ROE16.88%52W High37.78 -25.09%Perf Year1.36%
Cash/sh52.31P/FCF-EPS past 3/5Y-ROIC18.22%52W Low26.42 7.12%Perf 3Y-
Dividend Est.-EV/EBITDA3.30Sales past 3/5Y-Gross Margin98.01%Volatility1.58% 1.51%Perf 5Y-
Dividend TTM-EV/Sales1.50EPS Y/Y TTM-Oper. Margin57.14%ATR (14)0.68Perf 10Y-
Dividend Ex-Date-Quick Ratio30.30Sales Y/Y TTM-Profit Margin46.83%RSI (14)51.08Recom3.00
Dividend Gr. 3/5Y-Current Ratio30.48EPS Q/Q-98.22%SMA200.74%Beta0.72Target Price-
Payout0.00%Debt/Eq0.00Sales Q/Q-SMA500.44%Rel Volume0.95Prev Close28.37
Employees452LT Debt/Eq0.00EarningsAug 10SMA200-10.17%Avg Volume167.59KPrice28.30
IPO DateMay 05, 2005Option/ShortYes / YesEPS/Sales Surpr.126.21% -20.00%Net Debt/EBITDA-0.13Volume159,487Change-0.25%
Latest News
Jun-16-26
Jun-16-2604:03PM
Lakefront Biotherapeutics Repurchases 38,537 Of Its Own Shares Through June 9 - June 12Benzinga
Company
Ownership

Per-holder 13F data hasn't been ingested for this ticker yet.

Financial Statements
DataTimeframe
Line Item (USD, M)
TTM
—
FY 2025
12/31/2025
Total Revenue1,2141,255
Cost of Goods Sold Incl. D&A2534
Gross Profit1,1901,221
Selling, General and Administrative Excl. Other120126
Research and Development355518
Other Operating Expense1912
Operating Income695566
Interest Expense03
Unusual Expense
——
Non-Operating Income (Expense)138224
Net Income Before Taxes551339
Income Taxes-19-21
Consolidated Net Income572362
Net Income From Continuing Operations571360
Net Income572362
EPS (Recurring)8.685.49
EPS (Basic, Before Extraordinaries)8.685.49
EPS (Diluted)8.685.49
EBITDA557405
Other After Tax Adjustments
——
Stock Option Compensation Expense
——
Price To Earnings Ratio3.265.95
Price To Sales Ratio1.541.72
Gross Margin98.0297.29
Operating Margin57.2545.10
Net Margin47.1228.84
Shares Outstanding6666
Market Capitalization1,8682,158
Operating Lease Expense
——
Insider Trading Volume
$30.96$27.41$23.86$20.30$16.75● Close Price0.00K0.00K0.00K0.00K0.00KUSD Trades VolumeJunJulAugSepOctNovDec2026FebMarAprMayJun
open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR